{"title":"TENS in chronic pain management: a 11-year nationwide analysis using the French National Health Data System.","authors":"Vincent Arcani, Anne Donnet, Sylvain Redon","doi":"10.1080/14737167.2026.2691988","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic pain affects one in five people globally, frequently leading to complex polypharmacy. Transcutaneous electrical nerve stimulation (TENS) offers a non-pharmacological alternative to mitigate drug-related problems (DRPs) and reduce medication burden. This study evaluates a decade of real-world TENS utilization trends in France.</p><p><strong>Research design and methods: </strong>We conducted a nationwide retrospective study (2014-2024) using the French National Health Data System (Open LPP). Metrics included rental and purchase volumes, associated expenditures, and the purchase-to-rental (P/R) ratio, utilized as a behavioral proxy for long-term therapeutic persistence.</p><p><strong>Results: </strong>TENS initiations (rentals) increased 1.5-fold (91,709 to 158,947), while purchases grew 2.4-fold (17,362 to 41,784). Significant feminization was observed across all cohorts (<i>p</i> < 0.05). The overall P/R ratio was 22.7%. Women showed higher persistence than men (23.3% vs. 21.3%, <i>p</i> < 0.001). The highest persistence occurred in the 40-59 age group (25.4%), whereas the lowest was among patients under 19 (15.2%).</p><p><strong>Conclusion: </strong>TENS utilization in France shows a strong upward trend. While long-term adoption has improved, persistence remains limited, particularly in younger populations. The P/R ratio serves as a critical marker of clinical adoption and access dynamics.</p>","PeriodicalId":12244,"journal":{"name":"Expert Review of Pharmacoeconomics & Outcomes Research","volume":" ","pages":"769-775"},"PeriodicalIF":2.2000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Pharmacoeconomics & Outcomes Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14737167.2026.2691988","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/25 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Chronic pain affects one in five people globally, frequently leading to complex polypharmacy. Transcutaneous electrical nerve stimulation (TENS) offers a non-pharmacological alternative to mitigate drug-related problems (DRPs) and reduce medication burden. This study evaluates a decade of real-world TENS utilization trends in France.
Research design and methods: We conducted a nationwide retrospective study (2014-2024) using the French National Health Data System (Open LPP). Metrics included rental and purchase volumes, associated expenditures, and the purchase-to-rental (P/R) ratio, utilized as a behavioral proxy for long-term therapeutic persistence.
Results: TENS initiations (rentals) increased 1.5-fold (91,709 to 158,947), while purchases grew 2.4-fold (17,362 to 41,784). Significant feminization was observed across all cohorts (p < 0.05). The overall P/R ratio was 22.7%. Women showed higher persistence than men (23.3% vs. 21.3%, p < 0.001). The highest persistence occurred in the 40-59 age group (25.4%), whereas the lowest was among patients under 19 (15.2%).
Conclusion: TENS utilization in France shows a strong upward trend. While long-term adoption has improved, persistence remains limited, particularly in younger populations. The P/R ratio serves as a critical marker of clinical adoption and access dynamics.
期刊介绍:
Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review.
The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results
Article Highlights – an executive summary of the author’s most critical points.